MedPath
FDA Approval

Metaxalone

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
March 3, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Metaxalone(800 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

American Health Packaging

American Health Packaging

929561009

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Metaxalone

Product Details

NDC Product Code
60687-663
Application Number
ANDA207466
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 3, 2023
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
ALGINIC ACIDInactive
Code: 8C3Z4148WZClass: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
COPOVIDONE K25-31Inactive
Code: D9C330MD8BClass: IACT
SODIUM ALGINATEInactive
Code: C269C4G2ZQClass: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
Code: 1NMA9J598YClass: ACTIBQuantity: 800 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath